Codexis, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CDXS, updated each market day.
CDXS AI Sentiment
AI predicts Codexis, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Sector
Exchange
Market Cap
$218,086,437
Cap Tier
Employees
146
Headquarters
REDWOOD CITY, CA
Listed Since
April 22, 2010
Website
CDXS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CDXS Volatility
Codexis, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.